FANCL pathogenic variants
About
Gene context: FANCL
Biomarker Type: Germline Variant
Present: True
Chromosome: 2
Requires Pathogenic: True
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.Type | Biomarker(s) | Cancer type | Therapy(ies) | |
---|---|---|---|---|
Sensitivity (+) | FANCL pathogenic variants | Prostate Adenocarcinoma | Olaparib |